GL1X · GenesisL1 explorer

MolNFT v1 · #111320 · protein

The discovery of a-893, a new cell-active benzoxazinone inhibitor of lysine methyltransferase SMYD2

4YND · N-lysine methyltransferase SMYD2: “The discovery of a-893, a new cell-active benzoxazinone inhibitor of lysine methyltransferase SMYD2”. X-ray diffraction, 3 ligands (4GQ, SAM, ZN), 4 pockets (best druggability 0.81). MolNFT v1…

PDB
4YND
Type
protein
Length
428 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
N-lysine methyltransferase SMYD2
EC
2.1.1.-, 2.1.1.43
UniProt
Q9NRG4
Ligands
4GQ, SAM, ZN
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AN-lysine methyltransferase SMYD2 (EC 2.1.1.-, 2.1.1.43)protein42850% helix, 14% strandQ9NRG4

Ligands and binding sites

  • 4GQ · N-cyclohexyl-N~3~-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[(2R)-2-hydroxy-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-beta-alaninamide · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17230.810.8578SAM
21190.530.82254GQ
31040.460.7917empty
4990.410.7715empty

Compared structures

  • 4YND · The Discovery of A-893, A New Cell-Active Benzoxazi Inhibitor of Lysine Methyltransferase… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NRG4 · AlphaFold monomer V2.0 prediction for N-lysine methyltransferase SMYD2 (Q9NRG4) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.